Evidence map›Paper›PMID 27028903›Full record

ArticleBehavioural pharmacology2016

Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians.

Sunil Nayak, Adam Roberts, Kristofer Bires, Christopher S Tallarida, Erin Kim, Michael Wu, Scott M Rawls

Abstract read
In one paragraph

Article in Behavioural pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sunil NayakaCenter for Substance Abuse Research bDepartment of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Adam Roberts
Kristofer Bires
Christopher S Tallarida
Erin Kim
Michael Wu
Scott M Rawls
Temple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
Planarians and the pharmacology of addiction: an in vivo model for K-12 educationR25DA033270 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI RAWLS, SCOTT M. · 2014 to 2017
$1.0M
Mephedrone and addiction: clues from animal modelsR21DA032718 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI RAWLS, SCOTT M. · 2012 to 2013
$337k
NIDA NIH HHS P30 DA013429NIDA NIH HHS R21 DA032718NIDA NIH HHS R25 DA033270
6 · The paper itself

Abstract

Planarians spend less time in light versus dark environments. We hypothesized that planarians withdrawn from cocaine or ethanol would spend even less time in the light than drug-naive planarians and that a benzodiazepine would inhibit this response. Planarians pretreated in cocaine or ethanol were placed at the midline of a Petri dish containing spring water that was split evenly into dark and light compartments. Planarians withdrawn from cocaine (1, 10, 100 μmol/l) or ethanol (0.01%) spent less time in the light compartment than water controls; however, this withdrawal response to cocaine (100 μmol/l) or ethanol (0.01%) was abolished by clorazepate (0-100 μmol/l). These data suggest that planarians, similar to rodents, show benzodiazepine-sensitive, anxiogenic-like responses during cocaine or alcohol withdrawal.

Indexed as

AnimalsAnti-Anxiety AgentsBehavior, AnimalBenzodiazepinesClorazepate DipotassiumCocaineDarknessDose-Response Relationship, DrugEthanolLightPlanariansSubstance Withdrawal SyndromeTime FactorsAnti-Anxiety AgentsBenzodiazepinesClorazepate DipotassiumCocaineEthanol

Identifiers

PMID27028903
PMCPMC4965283
OpenAlexW2338951276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.